LABU ETF (Direxion Daily S&P Biotech Bull 3X ETF) is managed by Direxion Shares ETF Trust with $505.6M in net assets. LABU expense ratio is 0.93%, holding 153 positions across sectors including Health Care, Unknown, Other. Inception date: 2015-05-28.

LABU performance shows a YTD return of 5.35%. The 1-year return is 75.09% and the 5-year return is -41.74%. LABU dividend yield stands at 0.78%, paid quarterly.

LABU top holdings include Dreyfus Govt Cash Man Ins (21.6%), Goldman Sachs Fin Gov 465 Institut (13.3%), Gs Financial Square Treasury Instruments Fund (12.2%), NOK/USD Fwd 20240719 Deutgb2L (3.6%), Moderna therapeutics (0.9%). View all LABU holdings, sector breakdown, or dividend history.

LABU can be compared against other funds using the overlap calculator or side-by-side comparison tool. LABU alternatives are available via the screener, along with tax-loss harvesting opportunities.